4.6 Review

Selective inhibitors for JNK signalling: a potential targeted therapy in cancer

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/14756366.2020.1720013

关键词

JNK; selective inhibitors; cancer; tumour; SP60012; cancer therapy

资金

  1. National Natural Science Foundation of China [31972741, 31572575]
  2. Fundamental Research Funds for the Central Universities [2662016PY115]
  3. China Postdoctoral Science Foundation [2016T90477]
  4. Priority Academic Programme Development of Jiangsu Higher Education Institutions (PAPD)
  5. University of Hradec Kralove (Faculty of Science, VT2019-2021)
  6. Excellence project UHK

向作者/读者索取更多资源

c-Jun N-terminal kinase (JNK) signalling regulates both cancer cell apoptosis and survival. Emerging evidence show that JNK promoted tumour progression is involved in various cancers, that include human pancreatic-, lung-, and breast cancer. The pro-survival JNK oncoprotein functions in a cell context- and cell type-specific manner to affect signal pathways that modulate tumour initiation, proliferation, and migration. JNK is therefore considered a potential oncogenic target for cancer therapy. Currently, designing effective and specific JNK inhibitors is an active area in the cancer treatment. Some ATP-competitive inhibitors of JNK, such as SP600125 and AS601245, are widely used in vitro; however, this type of inhibitor lacks specificity as they indiscriminately inhibit phosphorylation of all JNK substrates. Moreover, JNK has at least three isoforms with different functions in cancer development and identifying specific selective inhibitors is crucial for the development of targeted therapy in cancer. Some selective inhibitors of JNK are identified; however, their clinical studies in cancer are relatively less conducted. In this review, we first summarised the function of JNK signalling in cancer progression; there is a focus on the discussion of the novel selective JNK inhibitors as potential targeting therapy in cancer. Finally, we have offered a future perspective of the selective JNK inhibitors in the context of cancer therapies. We hope this review will help to further understand the role of JNK in cancer progression and provide insight into the design of novel selective JNK inhibitors in cancer treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据